Vardeny O, Claggett B, Anand I, Rossignol P, Desai AS, Zannad F et al. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circulation: Heart Failure. 2014; 351. Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B et al. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 insights from RALES (Randomized Aldactone Evaluation Study). Journal of the American College of Cardiology. 2012; 60(20):2082-2089 352. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999; 353. Vasan RS, Xanthakis V, Lyass A, Andersson C, Tsao C, Cheng S et al. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades. JACC: Cardiovascular Imaging. 2018; 11(1):1-11 354. Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. Circulation: Heart Failure. 2017; 10(6) 355. Velazquez EJ. CABG added no benefit to medical therapy for preventing death in coronary artery disease with heart failure. Annals of Internal Medicine. 2011; 155(4):JC2-JC9 356. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. New England Journal of Medicine. 2011; 357. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. New England Journal of Medicine. 2016; 358. 